Apremilast survival and reasons for discontinuation in psoriasis: five-year experience from a Greek tertiary care centre

Apremilast survival and reasons for discontinuation in psoriasis: five-year experience from a Greek tertiary care centre

Introduction: Drug survival is an indirect measure of efficacy and safety and its post-marketing assessment using real-life data is invaluable. Objectives: To investigate the survival of apremilast in a cohort of psoriasis patients treated with apremilast in a Greek hospital. Methods: A retro...

Full description

Bibliographic Details
Main Authors: Elena Sotiriou, Aikaterini Tsentemeidou, Nikolaos Sideris, Aimilios Lallas, Nikolaos Kougkas, Dimitrios Ioannides, Efstratios Vakirlis
Format: Article
Language:English
Published: Mattioli1885 2022-05-01
Series:Dermatology Practical & Conceptual
Subjects:
psoriasis
apremilast
survival
discontinuation
Greece
Online Access:https://dpcj.org/index.php/dpc/article/view/1907

Internet

https://dpcj.org/index.php/dpc/article/view/1907

Similar Items